鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/09/25 | 3,855 | 3,935 | 3,850 | 3,925 | +110 | +2.9% | 29,500 |
| 2023/09/22 | 3,800 | 3,840 | 3,790 | 3,815 | +15 | +0.4% | 26,200 |
| 2023/09/21 | 3,785 | 3,855 | 3,785 | 3,800 | -10 | -0.3% | 16,700 |
| 2023/09/20 | 3,840 | 3,850 | 3,790 | 3,810 | -50 | -1.3% | 16,900 |
| 2023/09/19 | 3,870 | 3,885 | 3,830 | 3,860 | ±0 | ±0% | 16,300 |
| 2023/09/15 | 3,805 | 3,870 | 3,765 | 3,860 | +95 | +2.5% | 20,700 |
| 2023/09/14 | 3,795 | 3,795 | 3,710 | 3,765 | -35 | -0.9% | 19,300 |
| 2023/09/13 | 3,850 | 3,860 | 3,800 | 3,800 | -50 | -1.3% | 13,100 |
| 2023/09/12 | 3,790 | 3,855 | 3,780 | 3,850 | +80 | +2.1% | 15,400 |
| 2023/09/11 | 3,770 | 3,795 | 3,755 | 3,770 | +25 | +0.7% | 11,500 |
| 2023/09/08 | 3,715 | 3,765 | 3,715 | 3,745 | +10 | +0.3% | 20,900 |
| 2023/09/07 | 3,730 | 3,760 | 3,725 | 3,735 | -20 | -0.5% | 15,600 |
| 2023/09/06 | 3,770 | 3,770 | 3,720 | 3,755 | -40 | -1.1% | 20,700 |
| 2023/09/05 | 3,780 | 3,800 | 3,770 | 3,795 | +5 | +0.1% | 12,500 |
| 2023/09/04 | 3,830 | 3,830 | 3,770 | 3,790 | -10 | -0.3% | 25,400 |
| 2023/09/01 | 3,755 | 3,830 | 3,755 | 3,800 | +45 | +1.2% | 22,200 |
| 2023/08/31 | 3,750 | 3,765 | 3,700 | 3,755 | -35 | -0.9% | 27,700 |
| 2023/08/30 | 3,825 | 3,835 | 3,780 | 3,790 | -35 | -0.9% | 14,800 |
| 2023/08/29 | 3,765 | 3,825 | 3,765 | 3,825 | +40 | +1.1% | 19,300 |
| 2023/08/28 | 3,750 | 3,810 | 3,750 | 3,785 | +40 | +1.1% | 15,700 |
| 2023/08/25 | 3,670 | 3,750 | 3,665 | 3,745 | +45 | +1.2% | 21,200 |
| 2023/08/24 | 3,650 | 3,725 | 3,650 | 3,700 | +55 | +1.5% | 22,600 |
| 2023/08/23 | 3,615 | 3,650 | 3,615 | 3,645 | -5 | -0.1% | 11,200 |
| 2023/08/22 | 3,605 | 3,655 | 3,605 | 3,650 | +35 | +1% | 10,800 |
| 2023/08/21 | 3,565 | 3,635 | 3,565 | 3,615 | +10 | +0.3% | 9,000 |
| 2023/08/18 | 3,610 | 3,640 | 3,585 | 3,605 | -5 | -0.1% | 15,300 |
| 2023/08/17 | 3,610 | 3,610 | 3,565 | 3,610 | +10 | +0.3% | 13,600 |
| 2023/08/16 | 3,620 | 3,645 | 3,590 | 3,600 | -50 | -1.4% | 22,400 |
| 2023/08/15 | 3,615 | 3,660 | 3,600 | 3,650 | +5 | +0.1% | 14,200 |
| 2023/08/14 | 3,660 | 3,675 | 3,635 | 3,645 | +15 | +0.4% | 18,500 |
| 2023/08/10 | 3,565 | 3,640 | 3,540 | 3,630 | +55 | +1.5% | 14,200 |
| 2023/08/09 | 3,610 | 3,610 | 3,565 | 3,575 | -35 | -1% | 10,000 |
| 2023/08/08 | 3,600 | 3,620 | 3,595 | 3,610 | +10 | +0.3% | 10,000 |
| 2023/08/07 | 3,485 | 3,600 | 3,485 | 3,600 | +115 | +3.3% | 23,900 |
| 2023/08/04 | 3,530 | 3,530 | 3,465 | 3,485 | -45 | -1.3% | 27,300 |
| 2023/08/03 | 3,580 | 3,600 | 3,530 | 3,530 | -100 | -2.8% | 31,500 |
| 2023/08/02 | 3,630 | 3,665 | 3,580 | 3,630 | -5 | -0.1% | 44,800 |
| 2023/08/01 | 3,655 | 3,675 | 3,585 | 3,635 | +25 | +0.7% | 25,700 |
| 2023/07/31 | 3,625 | 3,650 | 3,575 | 3,610 | +55 | +1.5% | 31,200 |
| 2023/07/28 | 3,545 | 3,590 | 3,545 | 3,555 | -20 | -0.6% | 46,800 |
| 2023/07/27 | 3,540 | 3,575 | 3,535 | 3,575 | +40 | +1.1% | 10,200 |
| 2023/07/26 | 3,535 | 3,555 | 3,520 | 3,535 | -15 | -0.4% | 13,800 |
| 2023/07/25 | 3,595 | 3,605 | 3,535 | 3,550 | -35 | -1% | 21,700 |
| 2023/07/24 | 3,555 | 3,600 | 3,530 | 3,585 | +55 | +1.6% | 17,700 |
| 2023/07/21 | 3,560 | 3,565 | 3,515 | 3,530 | -5 | -0.1% | 29,900 |
| 2023/07/20 | 3,605 | 3,610 | 3,530 | 3,535 | -70 | -1.9% | 29,200 |
| 2023/07/19 | 3,560 | 3,605 | 3,550 | 3,605 | +105 | +3% | 31,400 |
| 2023/07/18 | 3,545 | 3,555 | 3,490 | 3,500 | -30 | -0.8% | 18,600 |
| 2023/07/14 | 3,500 | 3,550 | 3,490 | 3,530 | +10 | +0.3% | 52,800 |
| 2023/07/13 | 3,500 | 3,535 | 3,485 | 3,520 | +20 | +0.6% | 38,000 |
151～
200
件表示中 / 3451件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 403,500円 | +7.3% | +16.8% | 2.97% | 24.13倍 | 0.94倍 |
|
ＪＴ傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗ＨＩＶ薬の販売権喪失が直撃 |
| ジーエヌアイ | 239,400円 | +52.1% | +23.3% | 0.00% | 16.92倍 | 3.53倍 |
|
創薬ベンチャー。米国で人工骨も。中国の特発性肺線維症薬で高シェア、米中に研究開発機能 |
| 杏林製薬 | 182,200円 | +2.6% | +11.5% | 2.85% | 21.36倍 | 0.83倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ゼリア新薬 | 210,900円 | +6.8% | +18.7% | 2.09% | 13.28倍 | 1.23倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ＪＣＲファーマ | 79,900円 | +32.2% | +84.6% | 2.50% | 13.66倍 | 1.78倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
